Concepedia
Statistics
Publications
48
Citations
5.4K
H-Index
32
Active since
2006
Affiliations
Ionis Pharmaceuticals (United States)(Current)
University of Amsterdam
AstraZeneca (United Kingdom)
University of California, Davis
Cincinnati Children's Hospital Medical Center
Alexey S. Revenko is an author at Ionis Pharmaceuticals (United States) specializing in medicine, cell biology, and immunology.
Top concepts
MedicineCell BiologyImmunologyTumor BiologyCancer ResearchCancer BiologyNatural SciencesMolecular BiologyTumor MicroenvironmentInflammation
Publications per year
2006–2023
The Noncoding RNA <i>MALAT1</i> Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells
Tony Gutschner, Monika Hämmerle, Jeff Hsu et al. · Cancer Research · 2012 · 1.5K citations · Full text
AZD9150, a next-generation antisense oligonucleotide inhibitor of <i>STAT3</i> with early evidence of clinical activity in lymphoma and lung cancer
David S. Hong, Razelle Kurzrock, Youngsoo Kim et al. · Science Translational Medicine · 2015 · 428 citations · Full text
STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial
Matthew J. Reilley, Patricia McCoon, Carl Cook et al. · Journal for ImmunoTherapy of Cancer · 2018 · 275 citations · Full text
Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding
Alexey S. Revenko, Dacao Gao, Jeff Crosby et al. · Blood · 2011 · 206 citations · Full text
Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk
Hong Zhang, Ester Löwenberg, Jeffrey R. Crosby et al. · Blood · 2010 · 200 citations
1–5 of 48